Clinical Trial Update: 68Ga-AAZTA-093 PET/CT: First-in-human Study [EARLY_Phase 1]

View source ↗

Summary

An early-phase, first-in-human study evaluating the PET radiotracer 68Ga-AAZTA-093 for detecting prostate cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-AAZTA-093

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Malignant Neoplasm of Prostate | EARLY_Phase 1 | Status: RECRUITING